AXSM Axsome: Net earnings per share for the last 12 months
Axsome Therapeutics (AXSM) is implementing AI algorithms to develop antidepressants under the strict supervision of psychiatrists. Analyzing the annual EPS TTM growth helps identify the fading of profit drivers in a timely manner, with 34.50 representing the latest metric reading. The company relies on the repurposing of proven molecules to minimize risks, while simultaneously deploying automated packaging lines and digital trial data collection.
%20Axsome%20Therapeutics%2C%20Inc.&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_AXSM_-_Axsome-Therapeutics_-_Net-earnings-per-share-EPS-TTM "AXSM (axsome.com) Net earnings per one share for the last twelve months history from 02/11/2024 to 11/13/2026 | 👁️GURU.Markets👁️")
Axsome Therapeutics Inc - analytical breakdowns and key metrics (AXSM)
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization data:
- company total debt and liquidity indicators:
Aggregate Debt to Capital Axsome Therapeutics|AXSM - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Axsome Corp|AXSM - Company Aggregate Debts|Debts to Book Value Axsome|AXSM - Company Long-Term Debt|Company Short-Term Loans and Borrowings Axsome Therapeutics|Quick Ratio axsome.com
- net income and valuation ratios data:
AXSM - Company Net Income|Forward Earnings Axsome Therapeutics|AXSM - P/E Multiple|Projected Price to Earnings Ratio Axsome|AXSM - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Axsome|AXSM - Operating profit before deduction of amortization|Earnings per share for the last four quarters Axsome Therapeutics|AXSM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months axsome.com|AXSM - Earnings growth in current year|Expected earnings per share growth for next year Axsome Therapeutics
Fundamental company valuation:AXSM, axsome.com
The specificity of Axsome Therapeutics (AXSM) lies in the outsourcing of neuro-drug production, which minimizes environmental risks and capital expenditures. By analyzing the 12-month annual growth of earnings per share on GURU.Markets, an investor assesses the net income dynamics over a rolling year, separating market noise from real business acceleration to avoid purchasing overvalued assets during periods of dovish Fed policy.
Competitor analysis
Net earnings per one share for the last twelve months biogen.com|Neurocrine Biosciences, Inc. (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell Bioscience Ltd|ACAD (ACADIA Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Xenon Corp XENE|Net earnings per share for the last 12 months VKTX (Viking Therapeutics)|SUPN (supernus.com) - Earnings per share for the trailing year|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali)|Harmony Pharma - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (Biohaven Corp)|AMLX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months trevitherapeutics.com (TRVI)|Earnings per share for the last twelve months Praxis Precision Medicines, Inc.|AVXL: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CBLL|Net earnings per share (EPS TTM) Prothena Biosciences (PRTA)|Earnings per share for the last twelve months Alector ALEC|ANNX (annexonbio.com) - Earnings per one share for the last 12 months|Omeros Corp. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neurogene Inc|ACIU (AC Immune Corp) - Net earnings per share for the last 12 months|Voyager Corp (VYGR) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months NMRA|SCLX (scilexholding.com) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last four quarters alphacognition.com|Net earnings per share (EPS TTM) CGTX (Cognition Therapeutics)|IKT - Net earnings per share for the last 12 months|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio Holdings, Inc. ASRT|COYA: Net earnings per share (EPS TTM)|Vistagen (VTGN) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months OVID|Earnings per share for the last 12 months ABOS (Acumen Pharmaceuticals, Inc)|Earnings per share for the last twelve months CervoMed Inc. (CRVO)|Net earnings per share for the last four quarters alteritytherapeutics.com|Earnings per share for the last twelve months Clene CLNN|PEPG - Net earnings per share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (Relmada Corp) - Earnings per share for the last 12 months|ANVS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Grace Therapeutics (GRCE)|Net earnings per share for the last 12 months AIFF|Net earnings per share (EPS TTM) ANEW Medical, Inc.|Earnings per share for the last twelve months NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals, Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per one share for the last twelve months|Helius Medical Technologies Inc. - Net earnings per share (EPS TTM)|PASG - Net earnings per share (EPS TTM)|NEUP (bionomics.com.au) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months NERV|Earnings per share for the last twelve months Athira Pharma, Inc.|addextherapeutics.com (ADXN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Alzamend Neuro, Inc. (ALZN)|CYCN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Protagenic Therapeutics, Inc. PTIX|KTTA - Net earnings per share for the last 12 months|Cortigent Medical - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months avenuetx.com|BCLI (BrainStorm Cell Therapeutics) - Net earnings per share for the last 12 months|Cara Therapeutics Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months CHRO|ELYM (Eliem) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) ITCI|LBPH (longboardpharma.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) MRNS (Marinus Pharmaceuticals, Inc.)|NKGen Biotech Inc (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Earnings per share for the trailing year SAGE (Sage Therapeutics Inc)|SNPX: Net earnings per share (EPS TTM)|trevena.com (TRVN) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Vigil Neuroscience Inc.|Anew Medical Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CERE
